Company Filing History:
Years Active: 1993-2011
Title: Brian Down: Innovator in Pharmaceutical Patents
Introduction
Brian Down is a notable inventor based in Pierrefonds, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for various medical applications. With a total of 3 patents to his name, Down's work has had a meaningful impact on the treatment of several health conditions.
Latest Patents
One of Brian Down's latest patents is focused on granule formation, specifically relating to oral granules of montelukast sodium. This invention aims to improve the solubility of the compound, making it more effective for patients. Another significant patent involves amorphous (quinolin-2-ylmethoxy)indole compounds, which are useful for treating a range of conditions including asthma, allergies, and inflammation. This compound, derived from a specific chemical formula, has shown promise in treating various ailments such as diarrhea, hypertension, and migraines.
Career Highlights
Throughout his career, Brian Down has worked with prominent companies in the pharmaceutical industry, including Merck Frosst Canada, Inc. and Merck Frosst Canada & Co. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Brian Down has collaborated with various professionals in his field, including his coworker John Howard Hutchinson. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his inventions.
Conclusion
Brian Down's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through science. His patents reflect a deep understanding of medicinal chemistry and a dedication to developing effective treatments for patients.